Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/34435
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTurnidge J.en
dc.contributor.authorGrayson M.L.en
dc.date.accessioned2021-05-14T11:38:23Zen
dc.date.available2021-05-14T11:38:23Zen
dc.date.copyright1993en
dc.date.created19930426en
dc.date.issued2012-10-25en
dc.identifier.citationDrugs. 45 (3) (pp 353-366), 1993. Date of Publication: 1993.en
dc.identifier.issn0012-6667en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/34435en
dc.description.abstractSerious staphylococcal infections remain a significant clinical problem despite advances in antibacterial therapy. Resistance to penicillin is common and methicillin-resistant staphylococci have become troublesome nosocomial pathogens in many institutions. Penicillinase-resistant penicillins (e.g. flucloxacillin, cloxacillin and oxacillin) are the preferred drugs for all methicillin susceptible staphylococcal infections, although first generation cephalosporins, beta-lactam/beta-lactamase inhibitor combinations, clindamycin, and occasionally erythromycin and cotrimoxazole (trimethoprim/sulfamethoxazole) are alternatives. Serious infections due to methicillin-resistant staphylococci should be treated with parenteral vancomycin. Teicoplanin, where available, is a suitable alternative. Rifampicin, fusidic acid and some fluoroquinolones may be useful oral alternatives, although resistance develops rapidly if they are used as single agents. Cotrimoxazole and minocycline have also proven useful when strains are susceptible. Staphylococcal toxic shock syndrome often requires aggressive resuscitation and anti-staphylococcal therapy for generally 10 to 14 days. Staphylococcus aureus bacteraemia remains a life-threatening condition which, in all but one-third of cases, is associated with an underlying septic focus such as endocarditis, osteomyelitis or occult abscess. Differentiating between complicated and uncomplicated bacteraemia is critical to define the appropriate treatment regimen. Serious staphylococcal sepsis such as endocarditis and acute osteomyelitis generally requires prolonged (4 to 6 weeks) antibiotic treatment. Coagulase-negative staphylococci are the commonest cause of prosthetic device infection, and generally require prolonged therapy with an agent to which they have proven to be sensitive, e.g. a penicillinase-resistant penicillin or vancomycin. Removal of infected foreign or prosthetic material, and drainage of deep collections remain a critical aspect of all therapy.en
dc.languageenen
dc.languageEnglishen
dc.publisherAdis International Ltd (41 Centorian Drive, Private Bag 65901, Mairangi Bay, Auckland 10 1311, New Zealand)en
dc.titleOptimum treatment of Staphylococcal infections.en
dc.typeReviewen
dc.type.studyortrialReview article (e.g. literature review, narrative review)-
dc.publisher.placeNew Zealanden
dc.identifier.pubmedid7682906 [http://www.ncbi.nlm.nih.gov/pubmed/?term=7682906]en
dc.identifier.source23104122en
dc.identifier.institution(Turnidge, Grayson) Microbiology Department, Monash Medical Centre, Clayton Road, Clayton, Vic. 3168, Australiaen
dc.description.addressJ. Turnidge, Microbiology Department, Monash Medical Centre, Clayton Road, Clayton, Vic. 3168, Australiaen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2012 Elsevier B.V., All rights reserved.en
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeReview-
Appears in Collections:Articles
Show simple item record

Page view(s)

6
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.